Quorum Innovations Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
Quorum Innovations General Information
Description
Developer of a biotech company intended to discover and develop clinical therapeutics from Human Commensal Biofilm Microbiota (CBM). The company's technology focuses on human microbiome-derived biotherapeutics designed to treat barrier deficiency states, the therapeutics engage the body's immune system to treat a broad range of pathogens in biofilm form, enabling physicians to better solve the problem of antibiotic resistance.
Contact Information
Website
www.quoruminnovations.com
Formerly Known As
Quorum Biofilm Research Laboratories
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Primary Office
- 2068 Hawthorne Street
- Sarasota, FL 34236
- United States
+1 (941) 000-0000
Quorum Innovations Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 3. Early Stage VC (Series A) | Cancelled | Pre-Clinical Trials | ||||
| 2. Early Stage VC | Completed | Pre-Clinical Trials | ||||
| 1. Debt - General | 06-Feb-2014 | Completed | Pre-Clinical Trials |
Quorum Innovations Patents
Quorum Innovations Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021286002-A1 | Materials and methods for inhibiting a viral infection, including a coronavirus infection | Pending | 06-Jun-2020 | 0000000000 | |
| AU-2021268961-A1 | Novel protein, and therapeutic and cosmetic uses thereof | Pending | 06-May-2020 | 000000000000 | |
| CA-3176797-A1 | Novel protein, and therapeutic and cosmetic uses thereof | Pending | 06-May-2020 | 000000000000 | |
| EP-4064842-A2 | Novel protective barrier compositions, and uses thereof | Pending | 26-Nov-2019 | 000000000 | |
| US-11457633-B2 | Protective barrier compositions and uses thereof | Active | 26-Nov-2019 | A01N63/20 | 0 |
Quorum Innovations Executive Team (6)
Quorum Innovations Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Eva Berkes MD | Quorum Innovations | Co-Founder, Chief Scientific Officer, Principal & Board Member | 000 0000 |
| Fredrick Boehm JD | Quorum Innovations | Board Member, Vice President of Patent & Legal Affairs | 000 0000 |
| Nicholas Monsul MD | Quorum Innovations | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
Quorum Innovations Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
